Literature DB >> 31639048

Cardiovascular diseases risk factors among recently arrived Eritrean refugees in Switzerland.

Afona Chernet1,2, Nicole Probst-Hensch3,4, Véronique Sydow3,4, Daniel H Paris3,4, Andreas Neumayr3,4, Niklaus D Labhardt3,4,5.   

Abstract

OBJECTIVE: For the past 10 years, refugees from Eritrea represented the majority of asylum seekers in Switzerland. However, data on their health status remains limited. In this cross-sectional survey followed by a 1-year cohort study, we screened newly arrived Eritrean refugees for cardiovascular risk factors at arrival and 1-year post registration.
RESULTS: Among 107 participants (88.8% male; median age 25, 9 (9%) had a body mass index ≥ 25 kg/m2, one (1%) had elevated blood pressure, one (1%) had diabetes, 19% smoked and two (2%) had a low density lipoprotein (LDL) cholesterol ≥ 4.1 mmol/l. Among the 48 participants (5 females, 43 males) followed, there were no significant changes in cardiovascular risk profile 1 year post-arrival.

Entities:  

Keywords:  CVD risk factors; Eritrea; Migration; Refugees; Switzerland

Mesh:

Substances:

Year:  2019        PMID: 31639048      PMCID: PMC6805656          DOI: 10.1186/s13104-019-4715-0

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

In the past decade high numbers of refugees arrived in Europe. Focus of research on migrants’ health in host countries has mainly been on communicable infectious diseases. Little attention was given to the prevalence of cardiovascular diseases (CVDs) and their risk factors. However, CVDs are known to be on the rise in many African countries, including major source countries of refugees arriving in Europe [1]. The few studies available report adaption of new life style among immigrants in host countries exposing them to a higher CVD risk [2]. A US study revealed at least one non-communicable disease in more than half of recently arrived adult refugees [3]. Frequently diagnosed CVD risk factors are; high body mass index (BMI), elevated blood pressure (BP), and smoking. In a study conducted in Canada, 30% of refugees screened had elevated BP [4]. Médecins sans Frontières reports a 20.9% prevalence of CVDs among Syrian refugees arriving in Jordan [5]. There is, however, nearly no data on CVD risk profile among African migrants arriving in Europe. Switzerland is one of the major destinations of Eritrean refugees. During the last decade, the majority of African migrants in Switzerland, accounting for almost 30%, were Eritrean origin [6]. In this cohort-study we report CVD risk profile among Eritrean refugees at arrival and its change 1 year post arrival in Switzerland.

Main text

Methods

In two Swiss cantons (Basel-Stadt, Basel-Land), we enrolled Eritrean refugees from February to November 2016. After a written consent to take part in the study, participants were screened for infectious and non-infectious diseases at baseline and thereafter followed for 12 months. Detailed recruitment procedure and results from infectious diseases screening has been described previously [7]. In this short communication we report from the same cohort the CVD risk profile at baseline and 1-year follow-up. Study participants were eligible if they were aged 16 years and above, had arrived less than 1 year ago in Switzerland, had no physical complaints at recruitment and consented to the study. The recruitment period was driven by the study budget. We used a convenience sample-size including all individuals found eligible during the study-period. For CVD risk profile screening, they were interviewed about life-style habits and smoking, thereafter, body-weight and height, waist circumference and blood pressure were measured. Thereafter venous blood was collected at fasting state for measurement of glycated hemoglobin (HbA1c) and lipid-panel [total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), and triglycerides (TG)]. Screening was done at baseline and participants were re-contacted 1 year later for follow-up. Data were collected on paper format and subsequently entered into EpiInfo version 7 (CDC, 1600 Clifton Road, Atlanta, USA). Statistical analyses were performed in Stata version 13 (StataCorp LP, 4905 Lakeway Drive, College Station, USA). The study protocol was approved by the institutional research commission of the Swiss Tropical and Public Health Institute (Swiss TPH, Basel, Switzerland; reference no. FK 120; approval date: June 24, 2015) and the Ethics Committee of Northwest and Central Switzerland (reference no. EKNZ 2015-353; approval date: November 20, 2015). Participation was voluntary and people could withdraw from the study at any time without further obligations.

Results

A total of 107 (11.2% female) refugees were enrolled at baseline. Median age was 25 (interquartile range [IQR] 20–28) years. Table 1 presents prevalence of CVDs risk factors at baseline. Generally, participants had a favourable CVD risk profile at arrival. Overall, 48 (45%) attended the 1-year follow-up visit. The remaining had either moved to a different canton or outside Switzerland (45%) or declined participation at follow-up visit (10%). Table 2 compares baseline and follow-up measures among the 48 participants with complete data. There was no significant change in median blood pressure and cholesterol values at 1 year follow-up. However, BMI and HbA1c showed a very small, but significant trend of change.
Table 1

Cardio-vascular risk factors among newly arrived Eritrean refugees in Switzerland

MeasuresVariable (unit)CategoriesN (%)Median (IQR)
AgeAge (years)107 (100.0)2520–28
SmokingSmokingNon-smoker83 (77.6)NANA
Ex-smoker4 (3.7)NANA
Smoker20 (18.7)NANA
Body mass indexBMI (kg/m2)Over all107 (100.0)21.219.4–23.1
< 18.515 (14.0)17.116.8–18.2
≥ 18.5 and ≤ 24.983 (77.6)21.720.1–22.9
≥ 25.09 (8.6)27.226.5–28.1
Blood pressureSBP (mmHg)Over all117109–122
< 12067 (62.6)112103–116
≥ 120 and ≤ 13939 (36.4)123121–129
≥ 1401 (0.9)140NA
DBP (mmHg)Over all7064–77
< 8093 (86.9)6863–73
≥ 80 and ≤ 8913 (12.1)8381–87
≥ 901 (0.9)99NA
Glycated hemoglobinHbA1c (%)Over all5.04.8–5.2
< 5.699 (92.5)4.94.7–5.1
≥ 5.6 and < 6.57 (6.5)5.75.7–5.9
≥ 6.51 (0.9)6.6NA
Lipid panelTC (mmol/L) Over all3.93.3–4.5
< 5.1699 (92.5)3.83.1–4.2
≥ 5.16 and < 6.205 (4.7)5.65.4–5.7
≥ 6.203 (2.8)6.86.5–6.8
LDL (mmol/L) Over all2.21.8-2.7
< 3.35100 (93.5)2.11.5–2.5
≥ 3.35 and < 4.105 (4.7)3.53.5–3.7
≥ 4.102 (1.9)4.64.4–4.9
HDL (mmol/L) Over all1.21.0–1.4
< 3.0107 (100.0)1.11.0–1.4
≥ 3.00 (0.0)NANA
Triglycerides (mmol/L)Over all0.90.7–1.3
< 2.26104 (97.2)1.00.7–1.2
≥ 2.26 and < 4.503 (2.8)2.92.4–3.1
≥ 4.500 (0.0)NANA
TC to HDL ratio< 3.045 (42.1)2.52.1–2.7
≥ 3.062 (57.9)3.63.3–4.3

IQR interquartile range, NA not applicable

Table 2

Trend of lipid panel change at base-line and 1 year follow-up among recently migrated Eritrean refugees to Switzerland

ParametersCategoriesBase-lineFollow-upN = 48
N (%)Median (IQR)N (%)Median (IQR)Statistics
BMI
 Body mass index (kg/m2)Over all48 (100.0)21.719.2–23.148 (100.0)22.219.2–23.1t(47) = − 2.56; p = 0.01
< 18.57 (14.6)17.516.3–18.35 (10.4)17.516.8–18.2
≥ 18.5 and ≤ 24.934 (70.8)21.720.1–22.636 (75.0)22.021.0–23.1
≥ 25.07 (14.6)27.226.5–28.37 (14.6)27.925.6–28.3
Blood pressure
 Systolic blood pressure (mmHg)Over all48 (100.0)115.2108.5–120.548 (100.0)112.5108.5–120.0t(47) = 1.15; p = 0.26
< 12032 (66.7)112.0104.0–115.535 (72.9)111.0106.0–114.0
≥ 120 and ≤ 13916 (33.3)124.5120.5–130.513 (27.1)124.0123.0–126.0
≥ 14000
 Diastolic blood pressure (mmHg)Over all48 (100.0)71.064.0–77.048 (100.0)6863.0–72.5t(47) = 1.43; p = 0.16
< 8046 (95.8)70.564.0–76.045 (93.8)6663.0–71.0
≥ 80 and ≤ 892 (4.2)83.580.0–87.03 (6.2)8181.0–84.0
≥ 9000
HbA1c
 Glycated hemoglobin (%)Over all48 (100.0)5.04.8–5.148 (100.0)5.05.0–5.2t(47) = − 3.44; p = 0.001
< 5.645 (93.8)5.04.8–5.145 (93.8)5.05.0–5.2
≥ 5.6 and < 6.53 (6.2)5.75.6–5.83 (6.2)5.85.7–6.1
≥ 6.500
Cholesterol
 Total Cholesterol [TC] (mmol/L)Over all48 (100.0)4.03.3–4.648 (100.0)4.03.4–4.6t(47) = 0.80; p = 0.43
<5.1642 (87.5)3.93.2–4.443 (89.6)3.93.3–4.3
≥ 5.16 and < 6.204 (8.3)5.55.4–5.85 (10.4)5.45.3–5.4
≥ 6.202 (4.2)6.76.5–6.80
 Low density lipoprotein [LDL] (mmol/L)Over all48 (100.0)2.31.8–3.048 (100.0)2.21.7–2.5t(47) = 1.94; p = 0.06
< 3.3543 (89.6)2.11.7–2.545 (93.8)2.11.6–2.4
≥ 3.35 and < 4.104 (8.3)3.53.5–3.73 (6.2)3.93.5–3.9
≥ 4.101 (2.1)4.4NA0
 High density lipoprotein [HDL] (mmol/L)Over all48 (100.0)1.21.0–1.548 (100.0)1.31.1–1.4t(47) = 0.11; p = 0.92
< 3.048 (100.0)1.21.0–1.548 (100.0)1.31.1–1.4
≥ 3.000
 Triglycerides (mmol/L)Over all48 (100.0)1.00.8–1.448 (100.0)1.00.8–1.4t(47) = − 1.59; p = 0.12
< 2.2648 (100.0)1.00.8–1.443 (89.6)1.00.8–1.2
≥ 2.26 and < 4.5004 (8.3)2.62.3–3.0
≥ 4.5001 (2.1)5.3NA
 TC to HDL ratioOver all48 (100.0)3.22.8–3.848 (100.0)3.02.8–3.7t(47) = 1.08; p = 0.29
< 3.018 (37.5)2.62.4–2.921 (43.8)2.82.5–2.9
≥ 3.030 (62.5)3.73.2–4.427 (56.2)3.53.2–4.2

IQR interquartile range, NA not applicable

Cardio-vascular risk factors among newly arrived Eritrean refugees in Switzerland IQR interquartile range, NA not applicable Trend of lipid panel change at base-line and 1 year follow-up among recently migrated Eritrean refugees to Switzerland IQR interquartile range, NA not applicable

Discussion

In this cohort study Eritrean refugees had a very favourable CVD risk profile at arrival in Switzerland and CVD risk factors did not show any relevant change 1 year post arrival in the host country. This study has several limitations. First, most study participants were in their young age (median 24 years) where generally the CVD risk profile is low. Second, only half of participants could be followed at 1 year due to high numbers of participants moving to different areas in Switzerland or Europe. Third, the follow-up period of 1-year was rather short. In summary, our data are in line with survey data from Eritrea where the CVD risk profile in the general population was very low [8]. In our study, young Eritrean refugees had a very favorable CVD risk profile and showed no relevant increase in body-weight, cholesterol levels, blood pressure or blood glucose 1 year after arrival in Switzerland.

Limitations

Small sample size of participants. Relatively low participation of female refugees. Short follow-up time.
  5 in total

1.  Health status of newly arrived refugees in Toronto, Ont: Part 2: chronic diseases.

Authors:  Vanessa J Redditt; Daniela Graziano; Praseedha Janakiram; Meb Rashid
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

2.  High prevalence of chronic non-communicable conditions among adult refugees: implications for practice and policy.

Authors:  Katherine Yun; Kelly Hebrank; Lauren K Graber; Mary-Christine Sullivan; Isabel Chen; Jhumka Gupta
Journal:  J Community Health       Date:  2012-10

3.  Sex Differences and Predictors of Changes in Body Weight and Noncommunicable Diseases in a Random, Newly-Arrived Group of Refugees Followed for Two Years.

Authors:  K-L Catherine Jen; Hikmet Jamil; Kequan Zhou; Karen Breejen; Bengt B Arnetz
Journal:  J Immigr Minor Health       Date:  2018-04

4.  Spectrum of infectious diseases among newly arrived Eritrean refugees in Switzerland: a cross-sectional study.

Authors:  Afona Chernet; Andreas Neumayr; Christoph Hatz; Kerstin Kling; Véronique Sydow; Katharina Rentsch; Jürg Utzinger; Nicole Probst-Hensch; Hanspeter Marti; Beatrice Nickel; Niklaus D Labhardt
Journal:  Int J Public Health       Date:  2017-09-19       Impact factor: 3.380

5.  Cardiovascular disease risk and prevention amongst Syrian refugees: mixed methods study of Médecins Sans Frontières programme in Jordan.

Authors:  Dylan R J Collins; Kiran Jobanputra; Thomas Frost; Shoaib Muhammed; Alison Ward; Abed Alrazzaq Shafei; Taissir Fardous; Sadeq Gabashneh; Carl Heneghan
Journal:  Confl Health       Date:  2017-07-17       Impact factor: 2.723

  5 in total
  2 in total

1.  Assessment of ideal cardiovascular health metrics in refugees, East of Iran.

Authors:  Marjan Farzad; Toba Kazemi; Vida Mohammadparast; Saeede Khosravi Bizhaem; Zohreh Khazaee; Seddigheh Kianfar; Nahid Azdaki; Zabihullah Mohaghegh; Mahmoud Zardast
Journal:  J Diabetes Metab Disord       Date:  2021-09-03

2.  Mental health and resilience among Eritrean refugees at arrival and one-year post-registration in Switzerland: a cohort study.

Authors:  Afona Chernet; Nicole Probst-Hensch; Véronique Sydow; Daniel H Paris; Niklaus D Labhardt
Journal:  BMC Res Notes       Date:  2021-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.